Immune to Cancer: The CRI Blog
-
Coast to Coast for a Cure
Cyclist Joel Paula biked 4,000 miles to raise money for the Cancer Research Institute, and to prove…
-
FDA Approves New Cancer Immunotherapy
Merck's new immunotherapy, Keytruda (pembrolizumab), was approved today by the FDA, making it the first PD-1 inhibitor…
-
CRI Names Winners of Top Scientific Prize
Four scientists to be honored with the 2014 Coley Award for their contributions to the discovery of…
-
A Pilgrimage in Spain to Fight All Cancers
Having had four brothers battle cancer, David was inspired to make a 800km fundraising trek a journey…
-
When AIDS Was a Cancer
Before AIDS was recognized as an immune disorder, it was seen as a cancer. Find out what…
-
Two Immunotherapies Clear Important Regulatory Hurdles
The anti-PD-1 drug nivolumab receives the go-ahead for use in Japan, while in the U.S., CAR-T cells…
-
Making Pancreatic Cancer a Target for Immunotherapy
Researchers show that pancreatic cancer, long known to resist immunotherapy, can be made immunogenic after all.
-
How do you help patients find their hope?
Cynthia, an oncology nurse at Mount Sinai Hospital, has a front row seat for immunotherapy. Hear what…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.